Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis

Rydzewska, Larysa H.M., Burdett, Sarah, Vale, Claire L., Clarke, Noel W., Fizazi, Karim, Kheoh, Thian, Mason, Malcolm D. ORCID: https://orcid.org/0000-0003-1505-2869, Miladinovic, Branko, James, Nicholas D., Parmar, Mahesh K.B., Spears, Melissa R., Sweeney, Christopher J., Sydes, Matthew R., Tran, NamPhuong and Tierney, Jayne F. 2017. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. European Journal of Cancer 84 , pp. 88-101. 10.1016/j.ejca.2017.07.003

Preview

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution No Derivatives. Download (641kB) | Preview

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
ISSN:	0959-8049
Date of First Compliant Deposit:	21 September 2017
Date of Acceptance:	3 July 2017
Last Modified:	16 Nov 2024 12:15
URI:	https://orca.cardiff.ac.uk/id/eprint/104938

Citation Data

Cited 92 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item